ERCC1 Overexpression Increases Radioresistance in Colorectal Cancer Cells

SIMPLE SUMMARY: The 20–30% of locally advanced rectal cancer patients undergoing preoperative concurrent chemoradiotherapy had no expected efficacy, and ERCC1 overexpression was found in these tumor tissue patients. In the interest of confirming and adding details to our understanding of that correl...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yi-Jung, Huang, Ming-Yii, Cheng, Tian-Lu, Kuo, Shih-Hsun, Ke, Chien-Chih, Chen, Yi-Ting, Hsieh, Yuan-Chin, Wang, Jaw-Yuan, Cheng, Chiu-Min, Chuang, Chih-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563575/
https://www.ncbi.nlm.nih.gov/pubmed/36230725
http://dx.doi.org/10.3390/cancers14194798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563575/
https://www.ncbi.nlm.nih.gov/pubmed/36230725
http://dx.doi.org/10.3390/cancers14194798

Ejemplares similares